Total amount raised
$67 Millions
Latest funding date
Location
Levels has successfully raised significant funding through multiple rounds, with its latest being a Series A. The platform focuses on improving metabolic health using advanced biowearables and AI-powered insights.
Keep reading to explore the intricacies of Levels' fundraising journey and the investors backing this innovative health platform.
What Is Levels?
Levels, founded in June 2019, is a health and wellness company based in New York, New York. The company focuses on improving metabolic health through biowearables and AI-powered insights.
Founded by Andrew Conner, Casey Means, David Flinner, Josh Clemente, and Sam Corcos, Levels offers a platform that tracks blood glucose in real-time. This enables users to optimize their diet and exercise for better metabolic fitness.
With a team of 11-50 employees, Levels is dedicated to providing tools and insights that help users understand and improve their metabolic health.
How Much Funding Has Levels Raised?
- Pre-Seed Round
- Amount Raised: Not publicly disclosed
- Date: June 2019
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To kickstart the development of their metabolic health platform.
- Pre-Seed Round
- Amount Raised: Not publicly disclosed
- Date: January 2020
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To further develop the platform and prepare for market entry.
- Seed Round
- Amount Raised: $12M
- Date: November 2020
- Lead Investors: Andreessen Horowitz
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To expand the team and accelerate product development.
- Angel Round
- Amount Raised: Not publicly disclosed
- Date: January 2021
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To gain strategic advice and support from angel investors.
- Series A
- Amount Raised: $38M
- Date: April 2022
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To scale operations and enhance the platform's capabilities.
- Series A
- Amount Raised: $7M
- Date: January 2023
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To continue expanding the user base and improve product features.
- Series A Extension
- Amount Raised: $10M
- Date: August 2024
- Lead Investors: Long Journey, a16z
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To fund the development of a more accessible metabolic health app.
Total Amount Raised: $67M. Current Valuation: Not publicly disclosed.
Key Investors
- Andreessen Horowitz (a16z)
- Details: Andreessen Horowitz, also known as a16z, is a prominent venture capital firm based in Silicon Valley. Founded by Marc Andreessen and Ben Horowitz, the firm is known for its investments in both early-stage startups and established growth companies.
- Investment Focus Areas: Technology, healthcare, fintech, crypto, consumer.
- Notable Investments: Facebook, Airbnb, Coinbase.
- Long Journey Ventures
- Details: Long Journey Ventures is a venture capital firm that focuses on early-stage investments. The firm aims to support innovative companies with the potential to make a significant impact.
- Investment Focus Areas: Early-stage technology, innovative startups.
- Notable Investments: Specific notable investments are not publicly disclosed.
- Crowdfunding Investors
- Details: Over 2,000 individual investors participated in Levels' crowdfunding efforts. This community-driven approach aligns with Levels' mission of transparency and public engagement.
- Investment Focus Areas: Supporting innovative and promising startups.
- Notable Investments: Not applicable as these are individual investors rather than a single entity.
What's Next for Levels?
Levels is poised to capitalize on the growing interest in personalized health solutions. With over 60,000 members already benefiting from its platform, the company aims to expand its reach by leveraging AI-powered insights and large-scale research studies. The metabolic health crisis, affecting over 128 million Americans, presents a significant market opportunity for Levels to make a substantial impact.
Future fundraising efforts are likely to attract continued interest from both venture capital firms and individual investors, given the success of previous rounds. However, the company will need to navigate challenges such as data privacy, competition, and maintaining user engagement to sustain its growth trajectory.
Use Clay to Get Funding Data
Sales professionals, take your strategy to the next level by leveraging Clay's platform to access comprehensive fundraising data on companies like Levels and gather other critical business insights.
Sign up for free on Clay and start making data-driven decisions today.
